ACORN CAPITAL ADVISORS, LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$364.0M2026 Q3
Positions22
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.88.0%

ACORN CAPITAL ADVISORS, LLC reported 22 positions worth $364.0M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: CGON (22.0%). Biggest move: new buy ANTX ($6.9M).

10 / 22 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 CGONCG Oncology$80.2M22.04%1,131,500——+5.0%
▸ 2 URGNUroGen Pharma$67.0M18.40%1,648,420——-30.8%
▸ 3 PBYIPuma Biotechnology$41.0M11.27%4,131,299——-26.1%
▸ 4 CADLCandel Therapeutics$36.5M10.03%3,497,948——-40.6%
▸ 5 TRVITrevi Therapeutics$30.7M8.44%2,144,844——-7.2%
▸ 6 HELPHelus Pharma$18.9M5.20%1,540,266——-27.8%
▸ 7 JBIOJade Biosciences$13.9M3.81%986,760———
▸ 8 BCAXBicara Therapeutics$12.4M3.42%668,381——-46.2%
▸ 9 VSTMVerastem$11.8M3.25%1,469,153——-4.3%
▸ 10 OKUROnKure Therapeutics$7.8M2.13%2,839,674——-3.5%

Pro Feature

The remaining 12 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does ACORN CAPITAL ADVISORS, LLC hold as of Q3 2026?

ACORN CAPITAL ADVISORS, LLC reported 22 positions worth $364.0M in its Q3 2026 13F filing. Largest positions: CGON (22.0%), URGN (18.4%), PBYI (11.3%), CADL (10.0%) and TRVI (8.4%).

What did ACORN CAPITAL ADVISORS, LLC buy in Q3 2026?

New positions: ANTX and ANNX. Added to: ENGN, LONA, YARROW BIOSCIENCES INC, AURA and BCAX (6 in all).

What did ACORN CAPITAL ADVISORS, LLC sell in Q3 2026?

Reduced: URGN, WHWK and KPTI.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.